NetraMark Join Forces with Worldwide Clinical Trials to Redefine Clinical Trial Design Using NetraAI Platform
Shots:
- NetraMark and Worldwide Clinical Trials have entered into a global agreement to utilize NetraMark’s NetraAI platform to advance clinical trial design
- As per the deal, NetraAI will initially support P-II neuroscience & oncology trials, plus select P-III studies conducted by Worldwide, with broader access extended to Worldwide’s sponsors across all therapeutic areas & trial phases
- Collaboration will leverage Worldwide’s expertise & NetraMark AI platform to accelerate development, improve patient stratification, reduce PBO variability, enhance trial power, & deliver regulatory-aligned insights from complex datasets for advancing clinical trial success
Ref: Prnewswire | Image: NetraMark & Worldwide
Related News:- Suvoda Launches AI assistant Sofia to Streamline Clinical Trial Management
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
